Log In
Print
BCIQ
Print
Print this Print this
 

EGEN-001, GEN-1

  Manage Alerts
Collapse Summary General Information
Company Celsion Corp.
DescriptionIL-12-expressing plasmid formulated with a lipopolymeric gene delivery system
Molecular Target Interleukin-12 (IL-12)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$44.4M

$3.4M

$30.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today